Literature DB >> 20458801

Therapeutic benefit of pentoxifylline for Peyronie's disease.

Sarah Payton.   

Abstract

Entities:  

Year:  2010        PMID： 20458801     DOI： 10.1038/nrurol.2010.53

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease.

Authors:  Mohammad Reza Safarinejad; Majid Ali Asgari; Seyyed Yousof Hosseini; Farid Dadkhah
Journal:  BJU Int       Date:  2009-10-26       Impact factor: 5.588
  1 in total
  4 in total

1.  Pentoxifylline promotes recovery of erectile function in a rat model of postprostatectomy erectile dysfunction.

Authors:  Maarten Albersen; Thomas M Fandel; Haiyang Zhang; Lia Banie; Guiting Lin; Dirk De Ridder; Ching-Shwun Lin; Tom F Lue
Journal:  Eur Urol       Date:  2010-10-26       Impact factor: 20.096

2.  Patients with Peyronie's disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series.

Authors:  Gianni Paulis; Giovanni De Giorgio
Journal:  J Med Case Rep       Date:  2022-10-08

3.  Effects of pentoxifylline on renal structure after urethral obstruction in rat: A stereological study.

Authors:  Mehdi Shirazi; Ali Noorafshan; Amir Farrokhi
Journal:  Cent European J Urol       Date:  2011-03-18

4.  Peyronie's Disease Treated with Oral Weekly Dexamethasone and Continuous Low-dose Cyclophosphamide.

Authors:  Ramji Gupta; Sachi Gupta
Journal:  Indian J Dermatol       Date:  2014-05       Impact factor: 1.494
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.